Bids Are Invited For Acquisition Of Material For Specific Medicines Ii (Oncology)

Acquisition Of Material For Specific Medicines Ii (Oncology). Decitabine,Deferasirox,Degarelix,Degarelix,Denosumab,Denosumab,Ferric Derisomaltose,Dexrazoxane,Diphenhydramine Hydrochloride,Docetaxel,Docetaxel,Dostarlimab,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Dupilumab,Dupilumab,Durvalumab,Durvaluma Be,Elotuzumab,Eltrombopag Olamine,Eltrombopag Olamine , Enzalutamide, Epirubicin Hydrochloride, Epirubicin Hydrochloride, Coagulation Factor Concentrate, Erdafitinib, Erdafitinib, Erdafitinib, Eribulin Mesylate, Erlotinib, Erlotinib, Etanercept, Etanercept, Etoposide, Everolimus, Everolimus, Exemestane, Coagulation Factor Concentrate ,Concentrated Factor Coagulation,Fludarabine Phosphate,Fluoruracil,Fluoruracil,Calcium Folinate,Calcium Folinate,Fosaprepitant Dimeglumine,Fulvestrant,Gefitinib,Gemcitabine Hydrochloride,Gentuzumab Ozogamicin,Imatinib Mesylate,Golimumab,Golimumab,Goserelin Acetate,Gos Serrelin Acetate, Granisetron, Guselkumab, Hydroxyurea,Ibrutinib,Idarubicin Hydrochloride,Ifosfamide,Ifosfamide,Imatinib Mesylate,Imatinib Mesylate,Human Antithymocyte Immunoglobulin,Infliximab,Inotuzumab Ozogamicin,Interferon,Ipilimumab,Irinotecan Hydrochloride,Irinotecan Hydrochloride,Isatuximab,Isatuximab,Ixazomib,Ixa Zomib,Ixazomib,Ixekizumab,Lanreotide Acetate ,Lanreotide Acetate,Lanreotide Acetate,Lapatinib,Larotrectinib,Larotrectinib,Leflunomide,Lenalidomide